Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cheresh

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|October 15, 1991
Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligandR A Orlando, D A Cheresh
Oncogene|October 22, 2008
Regulation of angiogenesis: apoptotic cues from the ECMD A Cheresh, D G Stupack
Cancer Surveys|January 1, 1985
Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapyR A Reisfeld, D A Cheresh
Current Opinion in Cell Biology|September 7, 2001
Adhesion events in angiogenesisB P Eliceiri, D A Cheresh
The Journal of Biological Chemistry|February 11, 1994
A beta turn in the cytoplasmic tail of the integrin alpha v subunit influences conformation and ligand binding of alpha v beta 3E J Filardo, D A Cheresh
Current Opinion in Cell Biology|October 1, 1993
Vitronectin and its receptorsB Felding-Habermann, D A Cheresh
Cold Spring Harbor Symposia on Quantitative Biology|July 16, 2003
Targeted delivery of mutant Raf kinase to neovessels causes tumor regressionJ D Hood, D A Cheresh
The Journal of Biological Chemistry|December 25, 1987
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factorD A Cheresh, R C Spiro
Advances in Immunology|January 1, 1987
Human tumor antigensR A Reisfeld, D A Cheresh
The Journal of Cell Biology|May 1, 1986
Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectinD A Cheresh, F G Klier
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|October 15, 1991
Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha v beta 3 and its ligandR A Orlando, D A Cheresh
Oncogene|October 22, 2008
Regulation of angiogenesis: apoptotic cues from the ECMD A Cheresh, D G Stupack
Cancer Surveys|January 1, 1985
Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapyR A Reisfeld, D A Cheresh
Current Opinion in Cell Biology|September 7, 2001
Adhesion events in angiogenesisB P Eliceiri, D A Cheresh
The Journal of Biological Chemistry|February 11, 1994
A beta turn in the cytoplasmic tail of the integrin alpha v subunit influences conformation and ligand binding of alpha v beta 3E J Filardo, D A Cheresh
Current Opinion in Cell Biology|October 1, 1993
Vitronectin and its receptorsB Felding-Habermann, D A Cheresh
Cold Spring Harbor Symposia on Quantitative Biology|July 16, 2003
Targeted delivery of mutant Raf kinase to neovessels causes tumor regressionJ D Hood, D A Cheresh
The Journal of Biological Chemistry|December 25, 1987
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factorD A Cheresh, R C Spiro
Advances in Immunology|January 1, 1987
Human tumor antigensR A Reisfeld, D A Cheresh
The Journal of Cell Biology|May 1, 1986
Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectinD A Cheresh, F G Klier
Pageof 15